Finally, D20S107 is close to DNA topoisomerase I, a well-established molecular target of anticancer drugs, such as camptothecin derivatives, which are approved by the FDA for the treatment of colorectal tumors. The gene discussed is TOP1; the disease is colorectal neoplasm.